Carlsmed, which provides custom equipment and AI-enabled software for personalized spine fusion surgery, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. Carlsmed is focused on becoming the standard of care for spine fusion surgery. Its aprevo Technology Platform consists of AI-enabled software solutions, interbody implants custom designed for each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments. The company currently markets the aprevo Technology Platform for lumbar spine fusion surgery.
Read the full article: Spine Surgery-Focused Medtech Carlsmed Files for a $100M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/111767/Spine-surgery-focused-medtech-Carlsmed-files-for-a-$100-million-IPO